A detailed history of Handelsbanken Fonder Ab transactions in Merck & Co., Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 3,130,042 shares of MRK stock, worth $305 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
3,130,042
Previous 2,162,580 44.74%
Holding current value
$305 Million
Previous $268 Million 32.77%
% of portfolio
1.41%
Previous 1.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$111.15 - $128.97 $108 Million - $125 Million
967,462 Added 44.74%
3,130,042 $355 Million
Q2 2024

Aug 05, 2024

BUY
$123.8 - $132.96 $33.4 Million - $35.8 Million
269,554 Added 14.24%
2,162,580 $268 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $21.1 Million - $24.6 Million
186,134 Added 10.9%
1,893,026 $250 Million
Q4 2023

Feb 01, 2024

BUY
$100.18 - $109.02 $6.21 Million - $6.76 Million
62,026 Added 3.77%
1,706,892 $186 Million
Q3 2023

Oct 19, 2023

BUY
$102.95 - $114.33 $11.2 Million - $12.4 Million
108,654 Added 7.07%
1,644,866 $169 Million
Q2 2023

Aug 02, 2023

BUY
$108.61 - $118.38 $42.3 Million - $46.1 Million
389,764 Added 34.0%
1,536,212 $177 Million
Q1 2023

Apr 28, 2023

SELL
$102.94 - $114.86 $238,511 - $266,130
-2,317 Reduced 0.2%
1,146,448 $122 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $9.71 Million - $12.5 Million
111,078 Added 10.7%
1,148,765 $127 Million
Q3 2022

Oct 27, 2022

BUY
$84.53 - $94.96 $7.48 Million - $8.4 Million
88,503 Added 9.32%
1,037,687 $89.4 Million
Q2 2022

Aug 03, 2022

BUY
$83.49 - $94.64 $8.18 Million - $9.27 Million
97,921 Added 11.5%
949,184 $86.5 Million
Q1 2022

May 11, 2022

SELL
$73.51 - $82.4 $6.33 Million - $7.1 Million
-86,137 Reduced 9.19%
851,263 $69.8 Million
Q4 2021

Feb 08, 2022

SELL
$72.28 - $90.54 $19.4 Million - $24.3 Million
-268,402 Reduced 22.26%
937,400 $71.8 Million
Q3 2021

Nov 10, 2021

SELL
$71.68 - $78.83 $5.83 Million - $6.41 Million
-81,361 Reduced 6.32%
1,205,802 $90.6 Million
Q2 2021

Aug 03, 2021

BUY
$70.31 - $77.77 $10.1 Million - $11.2 Million
144,104 Added 12.61%
1,287,163 $100 Million
Q1 2021

Apr 29, 2021

BUY
$68.86 - $81.11 $15.9 Million - $18.7 Million
230,424 Added 25.25%
1,143,059 $88.1 Million
Q4 2020

Feb 11, 2021

BUY
$71.77 - $79.65 $8.47 Million - $9.4 Million
118,002 Added 14.85%
912,635 $74.7 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $1.9 Million - $2.15 Million
25,903 Added 3.37%
794,633 $65.9 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $45.6 Million - $51.9 Million
647,181 Added 532.44%
768,730 $59.4 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $36.1 Million - $50 Million
-569,134 Reduced 82.4%
121,549 $9.35 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $17 Million - $19.2 Million
-219,000 Reduced 24.07%
690,683 $62.8 Million
Q3 2019

Oct 31, 2019

BUY
$76.08 - $82.93 $380,400 - $414,650
5,000 Added 0.55%
909,683 $76.6 Million
Q2 2019

Jul 12, 2019

SELL
$69.84 - $81.59 $2.93 Million - $3.43 Million
-42,000 Reduced 4.44%
904,683 $75.9 Million
Q1 2019

May 10, 2019

BUY
$69.58 - $79.36 $565,963 - $645,514
8,134 Added 0.87%
946,683 $78.7 Million
Q4 2018

Jan 31, 2019

BUY
$65.24 - $75.71 $12.6 Million - $14.7 Million
193,549 Added 25.98%
938,549 $71.7 Million
Q3 2018

Oct 19, 2018

BUY
$57.69 - $67.84 $14.2 Million - $16.8 Million
247,000 Added 49.6%
745,000 $52.9 Million
Q2 2018

Jul 11, 2018

BUY
$50.83 - $59.72 $22.2 Million - $26.1 Million
437,000 Added 716.39%
498,000 $30.2 Million
Q1 2018

May 18, 2018

BUY
$50.96 - $59.23 $1.38 Million - $1.6 Million
27,000 Added 79.41%
61,000 $3.32 Million
Q4 2017

Feb 08, 2018

SELL
$51.62 - $61.64 $2.63 Million - $3.14 Million
-51,000 Reduced 60.0%
34,000 $1.91 Million
Q3 2017

Oct 24, 2017

BUY
$58.67 - $63.13 $4.99 Million - $5.37 Million
85,000
85,000 $5.44 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.